You are here: Home / GW Innovations / Technologies Available

Thinking outside the heart: Use of engineered cardiac tissue for treatment of chronic deep venous insufficiency

Technology #013-042-sarvazyan

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Image Gallery
Schematic of a "mini heart" wrapped around a blood vesselPhoto of a "mini heart" wrapped around a blood vesselSpontaneous pulsing of a cultured "mini heart" wrapped around a vein
Categories
Researchers
Dr. Narine Sarvazyan
External Link (www.lab.sarvazyan.com)
Managed By
Brian Coblitz
Sr. Licensing Associate coblitz@gwu.edu (202) 994-4345
Patent Protection

Provisional Patent Application Filed
Publications
Thinking Outside the Heart: Use of Engineered Cardiac Tissue for the Treatment of Chronic Deep Venous Insufficiency
J CARDIOVASC PHARMACOL THER, Published online before print February 4, 2014

Researchers at George Washington University invented a new organ that can return blood flow to veins lacking functioning valves. The organ is a rhythmic cuff made of cardiac muscle cells that surrounds the vein. The cuff acts as a “mini heart” to aid blood flow through the venous segments. It can be made of a patient’s own adult stem cells, eliminating the chance of implant rejection.

Chronic venous insufficiency is one of the most widespread diseases, particularly in developed countries. Its incidence can reach 20-30% in people over 50 years of age. In chronic venous insufficiency, blood pools in affected veins and doesn’t return to the heart efficiently. This can lead to swelling, skin changes, varicose veins, ulcerations, and even loss of limbs. Current treatment options for chronic venous disease, particularly for chronic deep vein insufficiency are limited.

Rather than just repairing a damaged organ, venous engineered heart tissue cuff is a new organ with capabilities greater than the initial veins themselves. GW researchers have shown feasibility of this novel approach in vitro and are currently working toward testing these devices in vivo.

The novel approach of creating ‘mini’ hearts may help to solve a chronic widespread disease. Meanwhile, it also demonstrates a leap for the tissue engineering field, taking it from organ repair to organ creation.

Applications:   Combat chronic deep vein insufficiency (CDVI)

Advantages:  

  • Restores blood flow to damaged veins
  • Uses patient’s own adult stem cells
  • Immature stem cells can be collected from a variety of sources
  • Simple design
  • Won’t cause cardiac arrhythmia or interfere with nearby muscles